Responses
Immunotherapy biomarkers
Original research
Non-invasive multimodal CT deep learning biomarker to predict pathological complete response of non-small cell lung cancer following neoadjuvant immunochemotherapy: a multicenter study
Compose a Response to This Article
Other responses
No responses have been published for this article.
